nodes	percent_of_prediction	percent_of_DWPC	metapath
Trovafloxacin—Lomefloxacin—ABCC2—esophageal cancer	0.0127	0.503	CrCbGaD
Trovafloxacin—Norfloxacin—CYP2A6—esophageal cancer	0.00872	0.344	CrCbGaD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT14—esophageal cancer	0.00569	0.0999	CbGpPWpGaD
Trovafloxacin—Hiccups—Capecitabine—esophageal cancer	0.00519	0.00565	CcSEcCtD
Trovafloxacin—Hyponatraemia—Cisplatin—esophageal cancer	0.00513	0.00559	CcSEcCtD
Trovafloxacin—Melaena—Capecitabine—esophageal cancer	0.00507	0.00552	CcSEcCtD
Trovafloxacin—Urinary incontinence—Capecitabine—esophageal cancer	0.00501	0.00546	CcSEcCtD
Trovafloxacin—Colitis—Capecitabine—esophageal cancer	0.00498	0.00543	CcSEcCtD
Trovafloxacin—Skin ulcer—Methotrexate—esophageal cancer	0.00496	0.0054	CcSEcCtD
Trovafloxacin—Candida infection—Capecitabine—esophageal cancer	0.00495	0.00539	CcSEcCtD
Trovafloxacin—Skin exfoliation—Capecitabine—esophageal cancer	0.00495	0.00539	CcSEcCtD
Trovafloxacin—Face oedema—Cisplatin—esophageal cancer	0.00493	0.00537	CcSEcCtD
Trovafloxacin—Gingivitis—Methotrexate—esophageal cancer	0.00492	0.00536	CcSEcCtD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—esophageal cancer	0.00464	0.0814	CbGpPWpGaD
Trovafloxacin—Cramp muscle—Cisplatin—esophageal cancer	0.0046	0.00501	CcSEcCtD
Trovafloxacin—Abnormal vision—Capecitabine—esophageal cancer	0.00452	0.00493	CcSEcCtD
Trovafloxacin—Sepsis—Capecitabine—esophageal cancer	0.0045	0.0049	CcSEcCtD
Trovafloxacin—Mental disability—Capecitabine—esophageal cancer	0.0045	0.0049	CcSEcCtD
Trovafloxacin—Speech disorder—Methotrexate—esophageal cancer	0.00449	0.00489	CcSEcCtD
Trovafloxacin—Thrombophlebitis—Capecitabine—esophageal cancer	0.00435	0.00474	CcSEcCtD
Trovafloxacin—Pancreatitis—Cisplatin—esophageal cancer	0.00433	0.00472	CcSEcCtD
Trovafloxacin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00431	0.00469	CcSEcCtD
Trovafloxacin—Sweating increased—Cisplatin—esophageal cancer	0.0043	0.00468	CcSEcCtD
Trovafloxacin—Photosensitivity—Capecitabine—esophageal cancer	0.00429	0.00467	CcSEcCtD
Trovafloxacin—Gastroenteritis—Capecitabine—esophageal cancer	0.00425	0.00463	CcSEcCtD
Trovafloxacin—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00425	0.00463	CcSEcCtD
Trovafloxacin—Pancytopenia—Cisplatin—esophageal cancer	0.00419	0.00457	CcSEcCtD
Trovafloxacin—Hepatic failure—Capecitabine—esophageal cancer	0.00419	0.00456	CcSEcCtD
Trovafloxacin—Eye pain—Capecitabine—esophageal cancer	0.00417	0.00454	CcSEcCtD
Trovafloxacin—Renal failure acute—Capecitabine—esophageal cancer	0.00408	0.00444	CcSEcCtD
Trovafloxacin—Libido decreased—Capecitabine—esophageal cancer	0.00406	0.00442	CcSEcCtD
Trovafloxacin—Hot flush—Capecitabine—esophageal cancer	0.00402	0.00438	CcSEcCtD
Trovafloxacin—Amnesia—Capecitabine—esophageal cancer	0.00401	0.00437	CcSEcCtD
Trovafloxacin—Increased appetite—Capecitabine—esophageal cancer	0.00401	0.00437	CcSEcCtD
Trovafloxacin—Menopausal symptoms—Capecitabine—esophageal cancer	0.00399	0.00435	CcSEcCtD
Trovafloxacin—Inflammation—Methotrexate—esophageal cancer	0.00398	0.00434	CcSEcCtD
Trovafloxacin—Renal impairment—Capecitabine—esophageal cancer	0.00396	0.00431	CcSEcCtD
Trovafloxacin—Thirst—Capecitabine—esophageal cancer	0.00396	0.00431	CcSEcCtD
Trovafloxacin—Respiratory failure—Methotrexate—esophageal cancer	0.00393	0.00428	CcSEcCtD
Trovafloxacin—Ciprofloxacin—ABCB1—esophageal cancer	0.00387	0.153	CrCbGaD
Trovafloxacin—Vaginal inflammation—Methotrexate—esophageal cancer	0.00386	0.00421	CcSEcCtD
Trovafloxacin—Stomatitis—Cisplatin—esophageal cancer	0.00384	0.00418	CcSEcCtD
Trovafloxacin—Conjunctivitis—Cisplatin—esophageal cancer	0.00383	0.00417	CcSEcCtD
Trovafloxacin—Hyponatraemia—Capecitabine—esophageal cancer	0.00378	0.00412	CcSEcCtD
Trovafloxacin—Melaena—Methotrexate—esophageal cancer	0.00377	0.00411	CcSEcCtD
Trovafloxacin—Osteoarthritis—Capecitabine—esophageal cancer	0.00376	0.0041	CcSEcCtD
Trovafloxacin—Diplopia—Capecitabine—esophageal cancer	0.00376	0.0041	CcSEcCtD
Trovafloxacin—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00373	0.00407	CcSEcCtD
Trovafloxacin—Migraine—Capecitabine—esophageal cancer	0.00371	0.00404	CcSEcCtD
Trovafloxacin—Skin exfoliation—Methotrexate—esophageal cancer	0.00369	0.00402	CcSEcCtD
Trovafloxacin—Vaginal infection—Methotrexate—esophageal cancer	0.00364	0.00397	CcSEcCtD
Trovafloxacin—Face oedema—Capecitabine—esophageal cancer	0.00363	0.00396	CcSEcCtD
Trovafloxacin—Aplastic anaemia—Methotrexate—esophageal cancer	0.00362	0.00395	CcSEcCtD
Trovafloxacin—Bradycardia—Cisplatin—esophageal cancer	0.0036	0.00392	CcSEcCtD
Trovafloxacin—Mood swings—Capecitabine—esophageal cancer	0.00357	0.00389	CcSEcCtD
Trovafloxacin—Ataxia—Capecitabine—esophageal cancer	0.00354	0.00386	CcSEcCtD
Trovafloxacin—Visual impairment—Cisplatin—esophageal cancer	0.0034	0.00371	CcSEcCtD
Trovafloxacin—Sepsis—Methotrexate—esophageal cancer	0.00335	0.00365	CcSEcCtD
Trovafloxacin—Gastritis—Capecitabine—esophageal cancer	0.00333	0.00363	CcSEcCtD
Trovafloxacin—Muscular weakness—Capecitabine—esophageal cancer	0.00332	0.00362	CcSEcCtD
Trovafloxacin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00332	0.00362	CcSEcCtD
Trovafloxacin—Tinnitus—Cisplatin—esophageal cancer	0.00329	0.00359	CcSEcCtD
Trovafloxacin—Flushing—Cisplatin—esophageal cancer	0.00328	0.00357	CcSEcCtD
Trovafloxacin—Dysphagia—Capecitabine—esophageal cancer	0.00325	0.00355	CcSEcCtD
Trovafloxacin—Asthma—Capecitabine—esophageal cancer	0.00325	0.00355	CcSEcCtD
Trovafloxacin—Thrombophlebitis—Methotrexate—esophageal cancer	0.00324	0.00353	CcSEcCtD
Trovafloxacin—Bronchospasm—Capecitabine—esophageal cancer	0.0032	0.00349	CcSEcCtD
Trovafloxacin—Photosensitivity—Methotrexate—esophageal cancer	0.00319	0.00348	CcSEcCtD
Trovafloxacin—Angina pectoris—Capecitabine—esophageal cancer	0.00317	0.00345	CcSEcCtD
Trovafloxacin—Sweating increased—Capecitabine—esophageal cancer	0.00317	0.00345	CcSEcCtD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—SFN—esophageal cancer	0.00316	0.0556	CbGpPWpGaD
Trovafloxacin—Hepatic failure—Methotrexate—esophageal cancer	0.00312	0.0034	CcSEcCtD
Trovafloxacin—Pancytopenia—Capecitabine—esophageal cancer	0.00309	0.00337	CcSEcCtD
Trovafloxacin—Dysuria—Capecitabine—esophageal cancer	0.00304	0.00332	CcSEcCtD
Trovafloxacin—Renal failure acute—Methotrexate—esophageal cancer	0.00304	0.00331	CcSEcCtD
Trovafloxacin—Flatulence—Cisplatin—esophageal cancer	0.00303	0.0033	CcSEcCtD
Trovafloxacin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00302	0.00329	CcSEcCtD
Trovafloxacin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00297	0.00324	CcSEcCtD
Trovafloxacin—Weight increased—Capecitabine—esophageal cancer	0.00296	0.00323	CcSEcCtD
Trovafloxacin—Muscle spasms—Cisplatin—esophageal cancer	0.00296	0.00322	CcSEcCtD
Trovafloxacin—Weight decreased—Capecitabine—esophageal cancer	0.00294	0.00321	CcSEcCtD
Trovafloxacin—Hyperglycaemia—Capecitabine—esophageal cancer	0.00294	0.0032	CcSEcCtD
Trovafloxacin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.0029	0.00316	CcSEcCtD
Trovafloxacin—Tremor—Cisplatin—esophageal cancer	0.00288	0.00314	CcSEcCtD
Trovafloxacin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00288	0.00313	CcSEcCtD
Trovafloxacin—Ill-defined disorder—Cisplatin—esophageal cancer	0.00285	0.00311	CcSEcCtD
Trovafloxacin—Anaemia—Cisplatin—esophageal cancer	0.00284	0.0031	CcSEcCtD
Trovafloxacin—Jaundice—Capecitabine—esophageal cancer	0.00283	0.00308	CcSEcCtD
Trovafloxacin—Stomatitis—Capecitabine—esophageal cancer	0.00283	0.00308	CcSEcCtD
Trovafloxacin—Conjunctivitis—Capecitabine—esophageal cancer	0.00282	0.00307	CcSEcCtD
Trovafloxacin—Osteoarthritis—Methotrexate—esophageal cancer	0.0028	0.00305	CcSEcCtD
Trovafloxacin—Malaise—Cisplatin—esophageal cancer	0.00277	0.00302	CcSEcCtD
Trovafloxacin—Leukopenia—Cisplatin—esophageal cancer	0.00275	0.003	CcSEcCtD
Trovafloxacin—Epistaxis—Capecitabine—esophageal cancer	0.00274	0.00298	CcSEcCtD
Trovafloxacin—Agranulocytosis—Capecitabine—esophageal cancer	0.00271	0.00295	CcSEcCtD
Trovafloxacin—Convulsion—Cisplatin—esophageal cancer	0.00266	0.0029	CcSEcCtD
Trovafloxacin—Mood swings—Methotrexate—esophageal cancer	0.00265	0.00289	CcSEcCtD
Trovafloxacin—Bradycardia—Capecitabine—esophageal cancer	0.00265	0.00289	CcSEcCtD
Trovafloxacin—Ataxia—Methotrexate—esophageal cancer	0.00264	0.00287	CcSEcCtD
Trovafloxacin—Myalgia—Cisplatin—esophageal cancer	0.00262	0.00285	CcSEcCtD
Trovafloxacin—Haemoglobin—Capecitabine—esophageal cancer	0.00262	0.00285	CcSEcCtD
Trovafloxacin—Rhinitis—Capecitabine—esophageal cancer	0.00261	0.00284	CcSEcCtD
Trovafloxacin—Anxiety—Cisplatin—esophageal cancer	0.00261	0.00284	CcSEcCtD
Trovafloxacin—Haemorrhage—Capecitabine—esophageal cancer	0.0026	0.00284	CcSEcCtD
Trovafloxacin—Hepatitis—Capecitabine—esophageal cancer	0.0026	0.00284	CcSEcCtD
Trovafloxacin—Hypoaesthesia—Capecitabine—esophageal cancer	0.00259	0.00282	CcSEcCtD
Trovafloxacin—Discomfort—Cisplatin—esophageal cancer	0.00259	0.00282	CcSEcCtD
Trovafloxacin—Oedema peripheral—Capecitabine—esophageal cancer	0.00257	0.0028	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00251	0.00274	CcSEcCtD
Trovafloxacin—Oedema—Cisplatin—esophageal cancer	0.00251	0.00274	CcSEcCtD
Trovafloxacin—Visual impairment—Capecitabine—esophageal cancer	0.00251	0.00273	CcSEcCtD
Trovafloxacin—Erythema multiforme—Capecitabine—esophageal cancer	0.00246	0.00268	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00246	0.00268	CcSEcCtD
Trovafloxacin—Tachycardia—Cisplatin—esophageal cancer	0.00245	0.00267	CcSEcCtD
Trovafloxacin—Skin disorder—Cisplatin—esophageal cancer	0.00244	0.00266	CcSEcCtD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—esophageal cancer	0.00243	0.0428	CbGpPWpGaD
Trovafloxacin—Tinnitus—Capecitabine—esophageal cancer	0.00243	0.00265	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Cisplatin—esophageal cancer	0.00243	0.00264	CcSEcCtD
Trovafloxacin—Asthma—Methotrexate—esophageal cancer	0.00242	0.00264	CcSEcCtD
Trovafloxacin—Flushing—Capecitabine—esophageal cancer	0.00242	0.00263	CcSEcCtD
Trovafloxacin—Eosinophilia—Methotrexate—esophageal cancer	0.0024	0.00261	CcSEcCtD
Trovafloxacin—Anorexia—Cisplatin—esophageal cancer	0.00239	0.00261	CcSEcCtD
Trovafloxacin—Pancreatitis—Methotrexate—esophageal cancer	0.00237	0.00259	CcSEcCtD
Trovafloxacin—Hypotension—Cisplatin—esophageal cancer	0.00235	0.00256	CcSEcCtD
Trovafloxacin—Chills—Capecitabine—esophageal cancer	0.00234	0.00255	CcSEcCtD
Trovafloxacin—Pancytopenia—Methotrexate—esophageal cancer	0.0023	0.00251	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00229	0.00249	CcSEcCtD
Trovafloxacin—Dysuria—Methotrexate—esophageal cancer	0.00226	0.00247	CcSEcCtD
Trovafloxacin—Paraesthesia—Cisplatin—esophageal cancer	0.00225	0.00246	CcSEcCtD
Trovafloxacin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00225	0.00245	CcSEcCtD
Trovafloxacin—Dyspnoea—Cisplatin—esophageal cancer	0.00224	0.00244	CcSEcCtD
Trovafloxacin—Flatulence—Capecitabine—esophageal cancer	0.00223	0.00243	CcSEcCtD
Trovafloxacin—Erectile dysfunction—Methotrexate—esophageal cancer	0.00223	0.00243	CcSEcCtD
Trovafloxacin—Dysgeusia—Capecitabine—esophageal cancer	0.00222	0.00242	CcSEcCtD
Trovafloxacin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00221	0.00241	CcSEcCtD
Trovafloxacin—Back pain—Capecitabine—esophageal cancer	0.00219	0.00239	CcSEcCtD
Trovafloxacin—Decreased appetite—Cisplatin—esophageal cancer	0.00218	0.00238	CcSEcCtD
Trovafloxacin—Muscle spasms—Capecitabine—esophageal cancer	0.00218	0.00237	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00217	0.00236	CcSEcCtD
Trovafloxacin—Pain—Cisplatin—esophageal cancer	0.00215	0.00234	CcSEcCtD
Trovafloxacin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00214	0.00233	CcSEcCtD
Trovafloxacin—Tremor—Capecitabine—esophageal cancer	0.00212	0.00231	CcSEcCtD
Trovafloxacin—Stomatitis—Methotrexate—esophageal cancer	0.00211	0.00229	CcSEcCtD
Trovafloxacin—Ill-defined disorder—Capecitabine—esophageal cancer	0.0021	0.00229	CcSEcCtD
Trovafloxacin—Conjunctivitis—Methotrexate—esophageal cancer	0.0021	0.00229	CcSEcCtD
Trovafloxacin—Anaemia—Capecitabine—esophageal cancer	0.0021	0.00228	CcSEcCtD
Trovafloxacin—Feeling abnormal—Cisplatin—esophageal cancer	0.00207	0.00225	CcSEcCtD
Trovafloxacin—Malaise—Capecitabine—esophageal cancer	0.00204	0.00223	CcSEcCtD
Trovafloxacin—Epistaxis—Methotrexate—esophageal cancer	0.00204	0.00222	CcSEcCtD
Trovafloxacin—Vertigo—Capecitabine—esophageal cancer	0.00204	0.00222	CcSEcCtD
Trovafloxacin—Syncope—Capecitabine—esophageal cancer	0.00203	0.00222	CcSEcCtD
Trovafloxacin—Leukopenia—Capecitabine—esophageal cancer	0.00203	0.00221	CcSEcCtD
Trovafloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—esophageal cancer	0.00202	0.0355	CbGpPWpGaD
Trovafloxacin—Agranulocytosis—Methotrexate—esophageal cancer	0.00202	0.0022	CcSEcCtD
Trovafloxacin—Palpitations—Capecitabine—esophageal cancer	0.002	0.00218	CcSEcCtD
Trovafloxacin—Loss of consciousness—Capecitabine—esophageal cancer	0.00199	0.00217	CcSEcCtD
Trovafloxacin—Body temperature increased—Cisplatin—esophageal cancer	0.00198	0.00216	CcSEcCtD
Trovafloxacin—Cough—Capecitabine—esophageal cancer	0.00198	0.00216	CcSEcCtD
Trovafloxacin—Hypertension—Capecitabine—esophageal cancer	0.00196	0.00213	CcSEcCtD
Trovafloxacin—Haemoglobin—Methotrexate—esophageal cancer	0.00195	0.00212	CcSEcCtD
Trovafloxacin—Hepatitis—Methotrexate—esophageal cancer	0.00194	0.00211	CcSEcCtD
Trovafloxacin—Haemorrhage—Methotrexate—esophageal cancer	0.00194	0.00211	CcSEcCtD
Trovafloxacin—Myalgia—Capecitabine—esophageal cancer	0.00193	0.0021	CcSEcCtD
Trovafloxacin—Arthralgia—Capecitabine—esophageal cancer	0.00193	0.0021	CcSEcCtD
Trovafloxacin—Chest pain—Capecitabine—esophageal cancer	0.00193	0.0021	CcSEcCtD
Trovafloxacin—Anxiety—Capecitabine—esophageal cancer	0.00192	0.0021	CcSEcCtD
Trovafloxacin—Discomfort—Capecitabine—esophageal cancer	0.00191	0.00208	CcSEcCtD
Trovafloxacin—Dry mouth—Capecitabine—esophageal cancer	0.00189	0.00206	CcSEcCtD
Trovafloxacin—Visual impairment—Methotrexate—esophageal cancer	0.00187	0.00204	CcSEcCtD
Trovafloxacin—Confusional state—Capecitabine—esophageal cancer	0.00187	0.00203	CcSEcCtD
Trovafloxacin—Oedema—Capecitabine—esophageal cancer	0.00185	0.00202	CcSEcCtD
Trovafloxacin—Hypersensitivity—Cisplatin—esophageal cancer	0.00185	0.00202	CcSEcCtD
Trovafloxacin—Erythema multiforme—Methotrexate—esophageal cancer	0.00183	0.002	CcSEcCtD
Trovafloxacin—Shock—Capecitabine—esophageal cancer	0.00182	0.00198	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00181	0.00197	CcSEcCtD
Trovafloxacin—Tinnitus—Methotrexate—esophageal cancer	0.00181	0.00197	CcSEcCtD
Trovafloxacin—Tachycardia—Capecitabine—esophageal cancer	0.00181	0.00197	CcSEcCtD
Trovafloxacin—Asthenia—Cisplatin—esophageal cancer	0.0018	0.00196	CcSEcCtD
Trovafloxacin—Skin disorder—Capecitabine—esophageal cancer	0.0018	0.00196	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Capecitabine—esophageal cancer	0.00179	0.00195	CcSEcCtD
Trovafloxacin—TOP2A—Circadian rythm related genes—CRTC1—esophageal cancer	0.00178	0.0312	CbGpPWpGaD
Trovafloxacin—Anorexia—Capecitabine—esophageal cancer	0.00176	0.00192	CcSEcCtD
Trovafloxacin—Chills—Methotrexate—esophageal cancer	0.00174	0.0019	CcSEcCtD
Trovafloxacin—Hypotension—Capecitabine—esophageal cancer	0.00173	0.00188	CcSEcCtD
Trovafloxacin—Diarrhoea—Cisplatin—esophageal cancer	0.00172	0.00187	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00169	0.00184	CcSEcCtD
Trovafloxacin—Insomnia—Capecitabine—esophageal cancer	0.00167	0.00182	CcSEcCtD
Trovafloxacin—Paraesthesia—Capecitabine—esophageal cancer	0.00166	0.00181	CcSEcCtD
Trovafloxacin—Dysgeusia—Methotrexate—esophageal cancer	0.00165	0.0018	CcSEcCtD
Trovafloxacin—Dyspnoea—Capecitabine—esophageal cancer	0.00165	0.0018	CcSEcCtD
Trovafloxacin—Back pain—Methotrexate—esophageal cancer	0.00163	0.00178	CcSEcCtD
Trovafloxacin—Dyspepsia—Capecitabine—esophageal cancer	0.00163	0.00177	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00161	0.0283	CbGpPWpGaD
Trovafloxacin—Decreased appetite—Capecitabine—esophageal cancer	0.00161	0.00175	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.0016	0.00174	CcSEcCtD
Trovafloxacin—Vomiting—Cisplatin—esophageal cancer	0.0016	0.00174	CcSEcCtD
Trovafloxacin—Fatigue—Capecitabine—esophageal cancer	0.0016	0.00174	CcSEcCtD
Trovafloxacin—Rash—Cisplatin—esophageal cancer	0.00158	0.00172	CcSEcCtD
Trovafloxacin—Pain—Capecitabine—esophageal cancer	0.00158	0.00172	CcSEcCtD
Trovafloxacin—Constipation—Capecitabine—esophageal cancer	0.00158	0.00172	CcSEcCtD
Trovafloxacin—Dermatitis—Cisplatin—esophageal cancer	0.00158	0.00172	CcSEcCtD
Trovafloxacin—Ill-defined disorder—Methotrexate—esophageal cancer	0.00157	0.00171	CcSEcCtD
Trovafloxacin—Anaemia—Methotrexate—esophageal cancer	0.00156	0.0017	CcSEcCtD
Trovafloxacin—Feeling abnormal—Capecitabine—esophageal cancer	0.00152	0.00166	CcSEcCtD
Trovafloxacin—Malaise—Methotrexate—esophageal cancer	0.00152	0.00166	CcSEcCtD
Trovafloxacin—Vertigo—Methotrexate—esophageal cancer	0.00152	0.00165	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00151	0.00165	CcSEcCtD
Trovafloxacin—Leukopenia—Methotrexate—esophageal cancer	0.00151	0.00165	CcSEcCtD
Trovafloxacin—Nausea—Cisplatin—esophageal cancer	0.00149	0.00162	CcSEcCtD
Trovafloxacin—Cough—Methotrexate—esophageal cancer	0.00147	0.0016	CcSEcCtD
Trovafloxacin—Urticaria—Capecitabine—esophageal cancer	0.00147	0.0016	CcSEcCtD
Trovafloxacin—Abdominal pain—Capecitabine—esophageal cancer	0.00146	0.00159	CcSEcCtD
Trovafloxacin—Body temperature increased—Capecitabine—esophageal cancer	0.00146	0.00159	CcSEcCtD
Trovafloxacin—Convulsion—Methotrexate—esophageal cancer	0.00146	0.00159	CcSEcCtD
Trovafloxacin—Chest pain—Methotrexate—esophageal cancer	0.00144	0.00157	CcSEcCtD
Trovafloxacin—Myalgia—Methotrexate—esophageal cancer	0.00144	0.00157	CcSEcCtD
Trovafloxacin—Arthralgia—Methotrexate—esophageal cancer	0.00144	0.00157	CcSEcCtD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.00142	0.025	CbGpPWpGaD
Trovafloxacin—Discomfort—Methotrexate—esophageal cancer	0.00142	0.00155	CcSEcCtD
Trovafloxacin—Confusional state—Methotrexate—esophageal cancer	0.00139	0.00151	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00138	0.0015	CcSEcCtD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—esophageal cancer	0.00137	0.0241	CbGpPWpGaD
Trovafloxacin—Hypersensitivity—Capecitabine—esophageal cancer	0.00136	0.00149	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00135	0.00147	CcSEcCtD
Trovafloxacin—Skin disorder—Methotrexate—esophageal cancer	0.00134	0.00146	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Methotrexate—esophageal cancer	0.00133	0.00145	CcSEcCtD
Trovafloxacin—Asthenia—Capecitabine—esophageal cancer	0.00133	0.00145	CcSEcCtD
Trovafloxacin—Anorexia—Methotrexate—esophageal cancer	0.00131	0.00143	CcSEcCtD
Trovafloxacin—Pruritus—Capecitabine—esophageal cancer	0.00131	0.00143	CcSEcCtD
Trovafloxacin—Hypotension—Methotrexate—esophageal cancer	0.00129	0.0014	CcSEcCtD
Trovafloxacin—Diarrhoea—Capecitabine—esophageal cancer	0.00127	0.00138	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00125	0.00137	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.00125	0.022	CbGpPWpGaD
Trovafloxacin—Insomnia—Methotrexate—esophageal cancer	0.00125	0.00136	CcSEcCtD
Trovafloxacin—Paraesthesia—Methotrexate—esophageal cancer	0.00124	0.00135	CcSEcCtD
Trovafloxacin—Dyspnoea—Methotrexate—esophageal cancer	0.00123	0.00134	CcSEcCtD
Trovafloxacin—Somnolence—Methotrexate—esophageal cancer	0.00122	0.00133	CcSEcCtD
Trovafloxacin—Dizziness—Capecitabine—esophageal cancer	0.00122	0.00133	CcSEcCtD
Trovafloxacin—Dyspepsia—Methotrexate—esophageal cancer	0.00121	0.00132	CcSEcCtD
Trovafloxacin—Decreased appetite—Methotrexate—esophageal cancer	0.0012	0.0013	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00119	0.0013	CcSEcCtD
Trovafloxacin—Fatigue—Methotrexate—esophageal cancer	0.00119	0.00129	CcSEcCtD
Trovafloxacin—Pain—Methotrexate—esophageal cancer	0.00118	0.00128	CcSEcCtD
Trovafloxacin—Vomiting—Capecitabine—esophageal cancer	0.00118	0.00128	CcSEcCtD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.00118	0.0207	CbGpPWpGaD
Trovafloxacin—Rash—Capecitabine—esophageal cancer	0.00117	0.00127	CcSEcCtD
Trovafloxacin—Dermatitis—Capecitabine—esophageal cancer	0.00117	0.00127	CcSEcCtD
Trovafloxacin—Headache—Capecitabine—esophageal cancer	0.00116	0.00126	CcSEcCtD
Trovafloxacin—Feeling abnormal—Methotrexate—esophageal cancer	0.00114	0.00124	CcSEcCtD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—PSME1—esophageal cancer	0.00113	0.0198	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—PSME2—esophageal cancer	0.00113	0.0198	CbGpPWpGaD
Trovafloxacin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00113	0.00123	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—AJUBA—esophageal cancer	0.00111	0.0195	CbGpPWpGaD
Trovafloxacin—Nausea—Capecitabine—esophageal cancer	0.0011	0.0012	CcSEcCtD
Trovafloxacin—Urticaria—Methotrexate—esophageal cancer	0.00109	0.00119	CcSEcCtD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—esophageal cancer	0.00109	0.0192	CbGpPWpGaD
Trovafloxacin—Abdominal pain—Methotrexate—esophageal cancer	0.00109	0.00119	CcSEcCtD
Trovafloxacin—Body temperature increased—Methotrexate—esophageal cancer	0.00109	0.00119	CcSEcCtD
Trovafloxacin—TOP2A—Gastric Cancer Network 2—MYC—esophageal cancer	0.00103	0.0181	CbGpPWpGaD
Trovafloxacin—Hypersensitivity—Methotrexate—esophageal cancer	0.00101	0.00111	CcSEcCtD
Trovafloxacin—TOP2A—Gastric Cancer Network 2—EGFR—esophageal cancer	0.00101	0.0177	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—AJUBA—esophageal cancer	0.000995	0.0175	CbGpPWpGaD
Trovafloxacin—Asthenia—Methotrexate—esophageal cancer	0.000988	0.00108	CcSEcCtD
Trovafloxacin—Pruritus—Methotrexate—esophageal cancer	0.000975	0.00106	CcSEcCtD
Trovafloxacin—Diarrhoea—Methotrexate—esophageal cancer	0.000942	0.00103	CcSEcCtD
Trovafloxacin—Dizziness—Methotrexate—esophageal cancer	0.000911	0.000992	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle—MLH3—esophageal cancer	0.000899	0.0158	CbGpPWpGaD
Trovafloxacin—Vomiting—Methotrexate—esophageal cancer	0.000876	0.000954	CcSEcCtD
Trovafloxacin—Rash—Methotrexate—esophageal cancer	0.000868	0.000946	CcSEcCtD
Trovafloxacin—Dermatitis—Methotrexate—esophageal cancer	0.000868	0.000945	CcSEcCtD
Trovafloxacin—Headache—Methotrexate—esophageal cancer	0.000863	0.00094	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00085	0.0149	CbGpPWpGaD
Trovafloxacin—TOP2A—Gastric Cancer Network 2—TP53—esophageal cancer	0.000847	0.0149	CbGpPWpGaD
Trovafloxacin—Nausea—Methotrexate—esophageal cancer	0.000818	0.000891	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000778	0.0137	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—GHRL—esophageal cancer	0.000774	0.0136	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.000758	0.0133	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00074	0.013	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000627	0.011	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000607	0.0107	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000607	0.0107	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000574	0.0101	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000563	0.0099	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000545	0.00957	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—esophageal cancer	0.000534	0.00938	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000533	0.00937	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—HIST1H2BM—esophageal cancer	0.000477	0.00838	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.000471	0.00828	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—esophageal cancer	0.000469	0.00824	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000452	0.00794	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—NOS2—esophageal cancer	0.000434	0.00762	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—MAD2L1—esophageal cancer	0.000421	0.0074	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.000414	0.00727	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.000414	0.00727	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000408	0.00716	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000406	0.00713	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—esophageal cancer	0.000396	0.00696	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—esophageal cancer	0.000383	0.00674	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.000377	0.00662	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.000371	0.00652	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—PSME2—esophageal cancer	0.00037	0.0065	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—PSME1—esophageal cancer	0.00037	0.0065	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.00035	0.00615	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.00034	0.00597	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—BUB1B—esophageal cancer	0.000337	0.00592	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000332	0.00584	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—CHEK2—esophageal cancer	0.00032	0.00563	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—esophageal cancer	0.000318	0.00559	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.0003	0.00528	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.00029	0.0051	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000276	0.00486	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	0.000265	0.00466	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000241	0.00423	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000236	0.00414	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000204	0.00359	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000198	0.00348	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000196	0.00344	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	0.00019	0.00334	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—RB1—esophageal cancer	0.000175	0.00307	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000172	0.00302	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	0.000154	0.0027	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000145	0.00255	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000141	0.00247	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000134	0.00235	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—CCND1—esophageal cancer	0.00013	0.00228	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	0.000126	0.00221	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—EP300—esophageal cancer	0.00012	0.0021	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000117	0.00205	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—MYC—esophageal cancer	0.000104	0.00183	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—TP53—esophageal cancer	8.56e-05	0.0015	CbGpPWpGaD
